| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 240.44B | 352.76B | 351.94B | 393.69B | 318.19B |
| Gross Profit | 70.50B | 77.87B | 77.98B | 101.78B | 76.54B |
| EBITDA | 40.45B | 41.13B | 44.48B | 67.13B | 47.51B |
| Net Income | -69.89B | 10.44B | 18.40B | 21.20B | 23.01B |
Balance Sheet | |||||
| Total Assets | 472.99B | 567.42B | 556.35B | 560.30B | 516.09B |
| Cash, Cash Equivalents and Short-Term Investments | 110.01B | 138.29B | 156.49B | 163.84B | 151.43B |
| Total Debt | 123.20B | 105.58B | 118.53B | 131.07B | 112.32B |
| Total Liabilities | 207.24B | 177.62B | 193.45B | 223.02B | 201.79B |
| Stockholders Equity | 261.33B | 383.64B | 357.26B | 331.89B | 304.56B |
Cash Flow | |||||
| Free Cash Flow | 23.85B | -1.15B | 12.29B | 8.15B | -3.60B |
| Operating Cash Flow | 42.75B | 28.41B | 39.33B | 37.56B | 15.64B |
| Investing Cash Flow | -19.80B | -34.22B | -27.09B | -33.32B | -19.13B |
| Financing Cash Flow | -42.05B | -22.65B | -24.27B | -409.00M | -12.72B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥239.71B | 9.64 | 8.91% | 3.85% | 1.48% | 8.86% | |
75 Outperform | ¥277.44B | 14.76 | ― | 2.50% | 6.16% | 17.11% | |
73 Outperform | ¥261.07B | 14.24 | ― | 1.65% | 14.49% | -21.17% | |
71 Outperform | ¥475.50B | 26.32 | 5.25% | 2.13% | -2.23% | 130.96% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
58 Neutral | $368.21B | 197.68 | 5.94% | 0.56% | 6.22% | ― | |
55 Neutral | ¥514.96B | -6.48 | 1.88% | 6.16% | 1.98% | -48.28% |